Factors Indicating Against Dose Escalation Maintain current dose when experiencing significant side effects at present level, achieving satisfactory subjective improvements (better sleep, energy, recovery), IGF-1 increased adequately (50+ ng/mL) for optimization goals, or financial constraints make higher dosing unsustainable
They slow digestion, reduce appetite, and influence reward pathways in the brain
Craving Control & Satiety Support Formulated with 10 clinically studied plant extracts and amino acids that help curb cravings, enhance meal satisfaction, and extend the feeling of fullness
DOI: 10.3390/ijms22136719 [Google Scholar] Philp AM, Collier RL, Grover LM, Davis ET, Jones SW
Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro